ARCHIVES

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

March 25, 2011

Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds

August 27, 2004

DCT Programs Status Reported to Board

July 5, 1985

In Brief: DOE honors radiation Therapy Pioneers; Center Honors Nixon, Lansing, Coffey

June 20, 1997

Pitot Supports Clearinghouse Modifications

January 20, 1978

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000